These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly. Liu SZ, Romeis JC. Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666 [Abstract] [Full Text] [Related]
8. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population. Hartung DM, Carlson MJ, Kraemer DF, Haxby DG, Ketchum KL, Greenlick MR. Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310 [Abstract] [Full Text] [Related]
9. Doctor pharmaceutical utilization behaviour changed by the global budget programme strategies on hypertensive outpatient prescription. Wei CK, Wang SM, Yeh MK. J Eval Clin Pract; 2012 Apr; 18(2):262-8. PubMed ID: 21040251 [Abstract] [Full Text] [Related]
10. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Hynd A, Roughead EE, Preen DB, Glover J, Bulsara M, Semmens J. Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671 [Abstract] [Full Text] [Related]
16. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use. Hansen RA, Schommer JC, Cline RR, Hadsall RS, Schondelmeyer SW, Nyman JA. Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472 [Abstract] [Full Text] [Related]